Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin-Reference-Cited by-同舟云学术

Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin

Published:2008-05 Issue:5 Volume:9 Page:294-299
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Manosuthi W,Mankatitham W,Lueangniyomkul A,Chimsuntorn S,Sungkanuparph S

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2008.00563.x/fullpdf

Reference28 articles.

1. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study

2. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

3. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

4. Survival Rate and Risk Factors of Mortality Among HIV/Tuberculosis-Coinfected Patients With and Without Antiretroviral Therapy

5. Treatment for Adult HIV Infection

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of Efavirenz 600mg in Combination with Rifampicin in Chinese HIV/TB Co-Infection Patients;Infection and Drug Resistance;2023-07

2. Integrase inhibitors versus efavirenz combination antiretroviral therapies for TB/HIV coinfection: a meta-analysis of randomized controlled trials;AIDS Research and Therapy;2021-05-01

3. Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial;BioMed Research International;2018-12-25

4. Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study;BMC Infectious Diseases;2017-12

5. Sub therapeutic drug levels among HIV/TB co-infected patients receiving Rifampicin in northwestern Tanzania: A cross sectional clinic based study;Alexandria Journal of Medicine;2017-08-01